| | 791835-21-7 Basic information More.. |
| Product Name: | BI-6C9 | | Synonyms: | N-[4-(4-aminophenyl)sulfanylphenyl]-4-[(4-methoxyphenyl)sulfonylamino]butanamide;Butanamide, N-[4-[(4-aminophenyl)thio]phenyl]-4-[[(4-methoxyphenyl)sulfonyl]amino]-;N-(4-((4-Aminophenyl)thio)phenyl)-4-(4-methoxyphenylsulfonamido)butanamide;Inhibitor,fission,Neurodegeneration,Bid,BI6C9,BI 6C9,Mitochodondrial,death,Mitochondria,Apoptosis,inhibit,Glutamate,stress,Neuronal,Bcl-2,Mitochondrial,Mitochondrial Metabolism,potential,cell,Oxidative,membrane,BI-6C9,BI-6C-9;BI-6C9, 10 mM in DMSO | | CAS: | 791835-21-7 | | MF: | C23H25N3O4S2 | | MW: | 471.59 | | EINECS: | | | Mol File: | 791835-21-7.mol |  |
Use
BH3-interacting domain (Bid) is cleaved by caspase-8 to produce the truncated protein tBid, which facilitates cytochrome c release from mitochondria and drives apoptosis. BI-6C9 is an inhibitor of tBid (Kd = 20 μM), blocking the release of both cytochrome c and second mitochondria-derived activator of caspase from mitochondria. It prevents apoptosis in neurons treated with glutamate or oxygen-glucose deprivation. BI-6C9 (10 μM) also inhibits the nuclear translocation of apoptosis-inducing factor AIF, preventing the death of ovarian OVCAR-3 cancer cells induced by IFN-α2a.
- BI-6C9
-
- US $60.00-147.00 / mg
- 2024-11-19
- CAS:791835-21-7
- Min. Order:
- Purity: 98%
- Supply Ability: 10g
|
|
791835-21-7
Recommend Suppliers |
|